Cannabis finance news

Losses narrow at Cymra Life Sciences as CEO bemoans ‘unfair trading conditions’

by Steve Jones November 13, 2024November 14, 2024

Byron Bay-based Cymra Life Sciences halved its losses in FY24 as sales rocketed to more than […]

Cannatrek CEO Tommy Huppert resigns with immediate effect

by Steve Jones November 8, 2024November 8, 2024

Cannatrek profits wiped out as costs soar

by Steve Jones November 7, 2024November 7, 2024

Company news: Wellnex Life; Rua Bioscience; Althea

by Steve Jones and Martin Lane November 6, 2024April 11, 2025

Cann Group extends deadline for cap raise as investors again told of ‘prosperous future’

by Steve Jones November 6, 2024April 11, 2025

Releaf creditors set to meet as business and assets go up for sale

by Steve Jones November 6, 2024November 7, 2024

Biortica inches closer to ASX backdoor listing with capital raise set for March

by Steve Jones November 5, 2024April 11, 2025

Althea reports cash flow positive quarter but shaves top end of revenue guidance

by Steve Jones October 31, 2024February 25, 2025

Releaf Group: receivers appointed to chase debt for law firm and administrators called in by board

by Steve Jones October 31, 2024October 31, 2024

Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue

by Steve Jones October 30, 2024October 30, 2024